EV/EBITDA
N/A
Thu, 13 Mar 2025 21:29:01 GMT
Summary
- ATXS EV/EBITDA is not available.
Performance
ATXS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ATXS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | - | - | -10.8% |
| 1 m1 month | - | - | -8.3% |
| 3 m3 months | - | - | -31.6% |
| 6 m6 months | - | - | -41.9% |
| ytdytd | - | - | -27.2% |
| 1 y1 year | - | - | -57.1% |
| 5 y5 years | - | - | -71.4% |
ATXS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.33 | |||
| 3 m | 3-month | -2.51 | -4.98 | ||
| 6 m | 6-month | -2.51 | -7.10 | ||
| 1 y | 1-year | -2.51 | -10.97 | ||
| 3 y | 3-year | 0.36 | -10.97 | ||
| 5 y | 5-year | 3.02 | -10.97 | ||
| alltime | all time | 3.02 | -10.97 |
Astria Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2023 | -2.06(-71.7%) |
| 2022 | -7.29(-1475.5%) |
| 2021 | 0.53(-203.9%) |
| 2020 | -0.51(-79.0%) |
| Date | Value |
|---|---|
| 2019 | -2.43(+291.9%) |
| 2018 | -0.62(-22.5%) |
| 2017 | -0.80(-44.4%) |
| 2016 | -1.44(-33.0%) |
| 2015 | -2.15 |
FAQ
- What is the all time high EV/EBITDA for Astria Therapeutics?
What is the all time high EV/EBITDA for Astria Therapeutics?
Astria Therapeutics all-time high EV/EBITDA is 3.02